|
DycloneDrug - Dyclone The trade name of the product as shown on the labeling.
Dosage -
SOLUTION; TOPICAL
Active Ingredient(s) -
Dyclonine Hydrochloride
Strength -
1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Applicant -
ASTRAZENECA
New Drug Application (NDA) Number -
009925
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Astrazeneca Lp
Dyclone
Yasmin 3mg;0.03mg Tablet; Oral-28
Cymbalta Eq 20mg Base Capsule, Delayed Rel Pellets; Oral Cymbalta Eq 30mg Base Capsule, Delayed Rel Pellets; Oral Cymbalta Eq 60mg Base Capsule, Delayed Rel Pellets; Oral Avodart 0.5mg Capsule; Oral Dyclone 0.5% **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Solution; Topical Dyclone 1% **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Solution; Topical Fentanyl Citrate And Droperidol 2.5mg/ml;eq 0.05mg Base/ml Injectable; Injection Innovar 2.5mg/ml;eq 0.05mg Base/ml Injectable; Injection Angeliq 0.5mg;1mg Tablet; Oral NewDrugInformation |